Aegis Sciences Launches Infectious Disease Testing

New product offers highly sensitive and specific, molecular testing solutions for common infectious diseases. Nashville, Tennessee (October 11, 2021) –…

New product offers highly sensitive and specific, molecular testing solutions for common infectious diseases. Nashville, Tennessee (October 11, 2021) – Aegis Sciences Corporation has expanded its molecular testing capabilities to rapidly identify pathogens in the respiratory and urogenital health spaces. With Aegis Infectious Disease Testing, providers will have access to: Clinically relevant tests…

National Surveillance of COVID-19 Infections: Variants, Vaccination Status, and Viral Spread

Aegis Sciences Corporation and Walgreens are collaborating to significantly improve access COVID-19 diagnostic testing throughout the United States. In…

Aegis Sciences Corporation and Walgreens are collaborating to significantly improve access COVID-19 diagnostic testing throughout the United States. In May 2021, Aegis began performing whole genome sequencing on samples identified as positive to assist in surveillance of transmissible viral variants. This has allowed for reporting of viral lineages from over 110,000 samples, accounting for ~15% of…

Aegis Launches COVID-19 Testing Program for Schools

TestingWorks! helps schools stay open through simple, cost-effective, pooled testing Nashville, Tennessee (June 10, 2021) –  Today, Aegis Sciences Corporation…

TestingWorks! helps schools stay open through simple, cost-effective, pooled testing Nashville, Tennessee (June 10, 2021) –  Today, Aegis Sciences Corporation launched TestingWorks! to help keep schools open during the COVID-19 pandemic through pooled testing. This testing program was designed to be simple for schools to use while reducing costs and increasing access to testing. “We’re at a critical…

Aegis Sciences Announces Additional Longer Term CDC Contract to Provide Genomic Sequencing of SARS-CoV-2 to Aid Public Health Response to COVID-19

Nashville, Tennessee (April 26, 2021) –  Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative COVID-19 and medication…

Nashville, Tennessee (April 26, 2021) –  Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative COVID-19 and medication compliance testing services, is pleased to announce that it has entered into a long term agreement with the Centers for Disease Control and Prevention (CDC) to deliver 10,000 SARS-CoV-2 genomic sequences per week to enable strain identification…

Aegis Sciences Corporation announces participation in National Testing Action Plan for K-12 Schools to Safely Reopen

Nashville, Tennessee (April 7, 2021) - The Rockefeller Foundation announced an initiative on March 26, to provide guidance on testing for K-12 public schools…

Nashville, Tennessee (April 7, 2021) - The Rockefeller Foundation announced an initiative on March 26, to provide guidance on testing for K-12 public schools to enable safe in-person learning. The K-12 National Testing Action Program: Connecting Schools with the Nation’s Leading Testing Companies to Safely Reopen (NTAP) connects schools with laboratories and testing partners, including Aegis Sciences…

Aegis Sciences Corporation Expands Novel Psychoactive Substance Testing

Nashville, Tennessee (April 5, 2021) –  Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance…

Nashville, Tennessee (April 5, 2021) –  Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers, is pleased to announce the expansion of novel psychoactive substance (NPS) testing to Aegis clients. Testing includes expanded offerings for designer opioids, designer benzodiazepines, synthetic cannabinoids,…

Aegis Sciences Announces Latest Innovation to Detect Patient Urine Substitution

Nashville, Tennessee (March 1, 2021) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance…

Nashville, Tennessee (March 1, 2021) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services, is pleased to announce the rollout of BioDetect™ to Aegis clients on March 1, 2021.  Aegis’ dedication to the development of clinically innovative testing solutions led to the creation of BioDetect™, a method designed…

Aegis Sciences Corporation and Walgreens announce expansion of COVID-19 diagnostic testing

The expanded relationship covering more than 3,000 locations will allow Walgreens to significantly increase its COVID-19 testing capacity Nashville,…

The expanded relationship covering more than 3,000 locations will allow Walgreens to significantly increase its COVID-19 testing capacity Nashville, Tenn. and Deerfield, Ill., (February 11, 2021) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers, and Walgreens today announced an expansion…

Aegis Sciences Corporation Expands Urine Drug Testing for Behavioral Health

Nashville, Tennessee (February 1, 2021) –  Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance…

Nashville, Tennessee (February 1, 2021) –  Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services, is pleased to announce the expansion of behavioral health testing (AcuRiseID™) to Aegis clients on February 1, 2021. Testing is now offered for over 100 medications and illicit drugs. The enhancement includes additional…

Aegis Sciences Corporation launches saliva testing for COVID-19

Aegis now offering a less invasive way of testing some patients for COVID-19

Aegis now offering a less invasive way of testing some patients for COVID-19